Melatonin and the neuropeptide PNX-14 inhibited microglia activation-mediated inflammation after stroke by suppressing the high expression and release of HMGB1 and modulating the subsequent activation of the TLR4/MyD88/NF-κB signaling pathway [185, 186]. The gene discussed is TLR4; the disease is Stroke.